230
Views
12
CrossRef citations to date
0
Altmetric
Review

The role of multi modality imaging in selecting patients and guiding lead placement for the delivery of cardiac resynchronization therapy

, , , , , , , , & show all
Pages 93-107 | Received 16 Aug 2016, Accepted 21 Oct 2016, Published online: 07 Nov 2016

References

  • Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol. 1994;17(11):1974–1979.
  • Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. (2009). N Engl J Med 2002; 346:1845-1853. Available from: http://dx.doi.org/10.1056/NEJMoa013168.
  • Cleland JGF, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–1549.
  • Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–2150.
  • Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2013;34(29):2281–2329.
  • Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. José Ramó N González-Juanatey. 2016.
  • Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51(3):288–296.
  • Foley PWX, Leyva F, Frenneaux MP. What is treatment success in cardiac resynchronization therapy? Europace. 2009;11(Suppl 5):v58–v65.
  • Rector TS, Kubo SH, Cohn J. Patients’ self-assessment of their congestive heart failure: content, reliability and validity of a new measure – the Minnesota Living with Heart Failure questionnaire. Heart Fail. 1987;3:198–209.
  • White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51.
  • Cohn JN. Remodeling as an end-point in heart failure therapy. Cardiovasc Drugs Ther. 2004;18(1):7–8.
  • Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569–582.
  • Matsumura Y, Hoshikawa-Nagai E, Kubo T, et al. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Cardiovasc Ultrasound. 2015;13:14.
  • Yu C-M, Zhang Q, Fung JW-H, et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol. 2005;45(5):677–684.
  • Ypenburg C, Van Bommel RJ, Borleffs CJW, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53(6):483–490.
  • Auricchio A, Stellbrink C, Sack S, et al. The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol. 1999;9149(99):0–5.
  • St. John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985–1990.
  • Abraham WT, Young JB, León AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110:2864–2868.
  • Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53(9):765–773.
  • Delnoy PPHM, Ottervanger JP, Luttikhuis HO, et al. Clinical response of cardiac resynchronization therapy in the elderly. Am Heart J. 2008;155(4):746–751.
  • Foley PWX, Chalil S, Khadjooi K, et al. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. J Work Groups Card Pacing, Arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol. 2008;10(11):1302–1307.
  • Sardu C, Marfella R, Santulli G. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res. 2014;7(3):362–368.
  • Grines CL, Bashore TM, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989;79(4):845–853.
  • Prinzen FW, Augustijn CH, Arts T, et al. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol. 1990;259(2 Pt 2):H300–8.
  • Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596–2603.
  • Yu C-M, Yang H, Lau C-P, et al. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol. 2003;26(2 Pt 1):562–570.
  • Fauchier L1, Marie O, Casset-Senon D, et al. Reliability of QRS duration and morphology on surface electrocardiogram to identify ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2003;92(3):341–344.
  • Gasparini M, Mantica M, Galimberti P, et al. Beneficial effects of biventricular pacing in patients with a “narrow” QRS. Pacing Clin Electrophysiol. 2003;26(1Pt 2):169–174.
  • Turner MS, Bleasdale RA, Vinereanu D, et al. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing. Circulation. 2004;109(21):2544–2549.
  • Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 1834–40;44(9):2004.
  • Yu C-M, Fung W-H, Lin H, et al. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91(6):684–688.
  • Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–2616.
  • Yu C-M, Sanderson JE, Gorcsan J, et al. Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy. Eur Heart J. 2010;31(19):2326–2337.
  • ZWDQTF of the N and SC of the AS of E, Quiñones MA1, Cm O, Stoddard M, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167–184.
  • Tee M, Noble JA, Bluemke DA. Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography. Expert Rev Cardiovasc Ther. 2013;11(2):221–231.
  • Oyenuga O1, Hara H, Tanaka H, et al. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2010;3(2):132–140.
  • Gorcsan J, Tanabe M, Bleeker GB, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50(15):1476–1483.
  • Sutton MS YCAS of EDWG, Gorcsan J 3rd1, Abraham T, Agler DA, et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting – a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21(3):191–213.
  • Kapetanakis S, Kearney MTT, Siva A, et al. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation. 2005;112(7):992–1000.
  • Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. http://dx.doi.org/10.1056/NEJMoa1306687. (2013).
  • Yu C-M, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart. 2003;89(1):54–60.
  • Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2012;126(14):1784–1800.
  • National Institute for Health and Care Excellence. NICE. Cardiac resynchronisation therapy for the treatment of heart failure. Technology appraisal guidance [TA120]. May 2007. Available from: https://www.nice.org.uk/guidance/ta120
  • National Institute for Health and Care Excellence. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure |Guidance and guidelines |NICE (TA314). NICE. 2014. Available from: https://www.nice.org.uk/guidance/ta314
  • Gardner BI, Bingham SE, Allen MR, et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. Cardiovasc Ultrasound. 2009;7:38.
  • Foley PWX, Khadjooi K, Ward JA, et al. Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure. J Cardiovasc Magn Reson. 2009;11:50.
  • Chalil S, Stegemann B, Muhyaldeen S, et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. PubMed Commons. J Am Coll Cardiol. 2007;50:243–252.
  • Sohal M, Shetty A, Duckett S, et al. Noninvasive assessment of LV contraction patterns using CMR to identify responders to CRT. JACC. Cardiovasc Imaging. 2013;6(8):864–873.
  • Pai VM, Axel L. Advances in MRI tagging techniques for determining regional myocardial strain. Curr Cardiol Rep. 2006;8(1):53–58.
  • Bilchick KC1, Dimaano V, Wu KC, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2008;5:561–568.
  • Belge B, Coche E, Pasquet A, et al. Accurate estimation of global and regional cardiac function by retrospectively gated multidetector row computed tomography: comparison with cine magnetic resonance imaging. Eur Radiol. 2006;16(7):1424–1433.
  • Truong QA, Singh JP, Cannon CP, et al. Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography. JACC. Cardiovasc Imaging. 2008;1(6):772–781.
  • Truong Q, Szymonifka J, Picard M, et al. Dual source computed tomographay to improve prediction of response to cardiac resynchronization therapy (DIRECT): a prospective double-blind randomized study. In American College of Cardiology Scientific Congress 2016. 2016.
  • Pourmorteza A, Schuleri KH, Herzka DA, et al. A new method for cardiac computed tomography regional function assessment: stretch quantifier for endocardial engraved zones (SQUEEZ). Circ Cardiovasc Imaging. 2012;5(2):243–250.
  • Pourmorteza A, Chen MY, Pals J, et al. Correlation of CT-based regional cardiac function (SQUEEZ) with myocardial strain calculated from tagged MRI: an experimental study. Int J Cardiovasc Imaging. 2016 May;32(5):817–823.
  • Ascione L1, Muto C, Iengo R, et al. End-diastolic wall thickness as a predictor of reverse remodelling after cardiac resynchronization therapy: a two-dimensional echocardiographic study. J Am Soc Echocardiogr. 2008;21(9):1055–1061.
  • Tuccillo B, Muto C, Iengo R, et al. Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy. J Interv Card Electrophysiol. 2008;23(2):121–126.
  • Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215–223.
  • Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness C. J Am Coll Cardiol. 2006;48(7):1475–1497.
  • Captur G, Manisty C, Moon JC. Cardiac MRI evaluation of myocardial disease. Heart. 2016;102:1429–1435.
  • Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–1453.
  • Bleeker GB, Kaandorp TAM, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113(7):969–976.
  • White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol. 2006;48(10):1953–1960.
  • Chalil S, Foley PWX, Muyhaldeen SA, et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace. 2007;9(11):1031–1037.
  • Tedrow U, Maisel WH, Epstein LM, et al. Feasibility of adjusting paced left ventricular activation by manipulating stimulus strength. J Am Coll Cardiol. 2004;44(11):2249–2252.
  • Schwartzman D, Chang I, Michele JJ, et al. Electrical impedance properties of normal and chronically infarcted left ventricular myocardium. J Interv Card Electrophysiol. 1999;3(3):213–224.
  • Ypenburg C, Roes SD, Bleeker GB, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99(5):657–660.
  • Petryka J, Miśko J, Przybylski A, et al. Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies. Eur J Radiol. 2012;81(10):2639–2647.
  • Leyva F1, Taylor RJ, Foley PW, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol. 2012;60(17):1659–1667.
  • Ginks MR, Duckett SG, Kapetanakis S, et al. Multi-site left ventricular pacing as a potential treatment for patients with postero-lateral scar: insights from cardiac magnetic resonance imaging and invasive haemodynamic assessment. Europace. 2012;14(3):373–379.
  • Lowe MD, Plummer CJ, Manisty CH, et al. Safe use of MRI in people with cardiac implantable electronic devices: figure 1. Heart. 2015;101:1950–1953.
  • Gerber BL, Belge B, Legros GJ, et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006;113(6):823–833.
  • Nicol ED, Stirrup J, Reyes E, et al. Comparison of 64-slice cardiac computed tomography with myocardial perfusion scintigraphy for assessment of global and regional myocardial function and infarction in patients with low to intermediate likelihood of coronary artery disease. J Nucl Cardiol. 2008;15(4):497–502.
  • Stirrup J, Nicol E, Underwood SR. Defining myocardial infarction by cardiac computed tomography. Int J Cardiovasc Imaging. 2008;24(8):891–893.
  • Nieman K, Cury RC, Ferencik M, et al. Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol. 2006;98(3):303–308.
  • Truong QA, Thai WEE, Wai B, et al. Myocardial scar imaging by standard single-energy and dual-energy late enhancement CT: comparison with pathology and electroanatomic map in an experimental chronic infarct porcine model. J Cardiovasc Comput Tomogr. 2014;9(4):313–320.
  • Watzke O, Kalender WA. A pragmatic approach to metal artifact reduction in CT: merging of metal artifact reduced images. Eur Radiol. 2004;14(5):849–856.
  • Zhao S, Robertson DD, Wang G, et al. X-ray CT metal artifact reduction using wavelets: an application for imaging total hip prostheses. IEEE Trans Med Imaging. 2000;19(12):1238–1247.
  • Wang G, Snyder DL, O’Sullivan JA, et al. Iterative deblurring for CT metal artifact reduction. IEEE Trans Med Imaging. 1996;15(5):657–664.
  • Chiang K-F, Cheng C-M, Tsai S-C, et al. Relationship of myocardial substrate characteristics as assessed by myocardial perfusion imaging and cardiac reverse remodeling levels after cardiac resynchronization therapy. Ann Nucl Med. 2016;30(7):484–493.
  • Ypenburg C, Schalij MJ, Bleeker GB, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28(1):33–41.
  • Chen J1, Garcia EV, Folks RD, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12(6):687–695.
  • Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59(17):1509–1518.
  • Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the speckle tracking assisted resynchronization therapy for electrode region trial. Circ Heart Fail. 2013;6(3):427–434.
  • Leyva F, Foley PWX, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13(1):29.
  • Singh JP, Klein HU, Huang DT, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2011;123(11):1159–1166.
  • Stellbrink C, Auricchio A, Butter C, et al. Pacing therapies in congestive heart failure II study. Am J Cardiol. 2000;86(9A):138K-143K.
  • Rossillo A, Verma A, Saad EB, et al. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol. 2004;15(10):1120–1125.
  • Duckett SG, Ginks MR, Shetty AK, et al. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2011;58(11):1128–1136.
  • Sommer A, Kronborg MB, Nørgaard BL, et al. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Eur J Heart Fail. 2016. doi: 10.1002/ejhf.530. [Epub ahead of print].
  • Bai R, Di Biase L, Mohanty P, et al. Positioning of left ventricular pacing lead guided by intracardiac echocardiography with vector velocity imaging during cardiac resynchronization therapy procedure. J Cardiovasc Electrophysiol. 2011;22(9):1034–1041.
  • Jin Y, Zhang Q, Mao J-L HB. Image-guided left ventricular lead placement in cardiac resynchronization therapy for patients with 7heart failure: a meta-analysis. BMC Cardiovasc Disord. 2015;15:36.
  • Wong JA, Yee R, Stirrat J, et al. Influence of pacing site characteristics on response to cardiac resynchronization therapy. Circ Cardiovasc Imaging. 2013;6(4):542–550.
  • Duckett SG, Ginks M, Shetty A, et al. Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position. J Interv Card Electrophysiol. 2012;33(2):151–160.
  • Tse HF1, Yu C, Wong KK, et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol. 2002;40(8):1451–1458.
  • Hay I, Melenovsky V, Fetics BJ, et al. Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block. Circulation. 2004;110(22):3404–3410.
  • Heist EK, Fan D, Mela T, et al. Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy. Am J Cardiol. 2005;96(5):685–690.
  • Shetty AK, Duckett SG, Ginks MR, et al. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling. Eur Heart J Cardiovasc Imaging. 2013;14(7):692–699.
  • Laksman Z, Yee R, Stirrat J, et al. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single centre feasibility study. Circ Arrhythm Electrophysiol. 2014;7:1040–1047.
  • Nguyên UC, Mafi-Rad M, Aben J-P, et al. A novel approach for left ventricular lead placement in cardiac resynchronization therapy: intra-procedural integration of coronary venous electro-anatomic mapping with delayed enhancement cardiac magnetic resonance imaging. Heart Rhythm. 2016. [Epub ahead of print].
  • Eitel C, Döring M, Gaspar T, et al. Cardiac resynchronization therapy with individualized placement of two left ventricular leads at the sites of latest mechanical left ventricular contraction: guided by 3D-echocardiography and coronary sinus rotation angiography. Eur J Heart Fail. 2010;12(4):411–414.
  • Niederer SA, Smith NP. Using physiologically based models for clinical translation: predictive modelling, data interpretation or something in-between? J Physiol. 2016 Apr 28. doi: 10.1113/JP272003. [Epub ahead of print].
  • Sperzel J, Danschel W, Gutleben K-JK-J, et al. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace. 2012;14(3):365–372.
  • Behar JM, Bostock J, Li AP Z, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry. J Cardiovasc Electrophysiol. 2015;26(5):540–546.
  • Niederer SA, Shetty AK, Plank G, et al. Biophysical modeling to simulate the response to multisite left ventricular stimulation using a quadripolar pacing lead. Pacing Clin Electrophysiol. 2012;35(2):204–214.
  • De Ponti R. Reduction of radiation exposure in catheter ablation of atrial fibrillation: lesson learned. World J Cardiol. 2015;7(8):442–448.
  • Thibault B, Mondésert B, Macle L, et al. Reducing radiation exposure during crt implant procedures: single-center experience with low-dose fluoroscopy settings and a sensor-based navigation system (Mediguide). J Cardiovasc Electrophysiol. 2016 Jul 26. doi: 10.1111/jce.13048. [Epub ahead of print].
  • Spragg DD, Dong J, Fetics BJ, et al. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2010;56(10):774–781.
  • Amraoui S, Bordachar P, Ritter P, et al. Hemodynamic optimization of transseptal LV endocardial pacing site during a definitive implantation of a CRT device: the long-term follow up. Hear Rhythm. 2014;11(5):S92.
  • Hyde ER, Behar JM, Claridge S, et al. Beneficial effect on cardiac resynchronization from left ventricular endocardial pacing is mediated by early access to high conduction velocity tissue: electrophysiological simulation study. Circ Arrhythmia Electrophysiol. 2015;8(5):1164–1172.
  • Garrigue S, Jaïs P, Espil G, et al. Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure. Am J Cardiol. 2001;88(8):858–862.
  • Morgan JM, Biffi M, Gellér L, et al. ALternate site cardiac resYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. Eur Heart J. 2016;ehv723. [Epub ahead of print].
  • Betts TR, Gamble JHP, Khiani R, et al. Development of a technique for left ventricular endocardial pacing via puncture of the interventricular septum. Circ Arrhythmia Electrophysiol. 2014;7(1):17–22.
  • Auricchio A, Delnoy -P-P-P-P, Butter C, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study. Europace. 2014;16(5):681–688.
  • Mafi Rad M, Blaauw Y, Dinh T, et al. Left ventricular lead placement in the latest activated region guided by coronary venous electroanatomic mapping. Europace. 2015 Jan;17(1):84-93. doi: 10.1093/europace/euu221. Epub 2014 Sep 3.
  • Sardu C, Santamaria M, Rizzo MR, et al. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART study. Int J Clin Pract. 2016;70(7):569–576.
  • Miller MA, Neuzil P, Dukkipati SR, et al. Leadless cardiac pacemakers. J Am Coll Cardiol. 2015;66(10):1179–1189.
  • Behar JM, Jackson T, Hyde E, et al. Optimized left ventricular endocardial stimulation is superior to optimized epicardial stimulation in ischemic patients with poor response to cardiac resynchronization therapy. JACC Clin Electrophysiol. 2016. doi:10.1016/j.jacep.2016.04.006
  • Bordachar P, Derval N, Ploux S, et al. Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol. 2010;56(10):747–753.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.